It is estimated that around 73,000 people in Britain are infected with HIV, or human immunodeficiency virus, which culminates in Aids. Although HIV infection is still considered serious, an early diagnosis and treatment can allow a patient to live a relatively normal lifespan.
HIV continually changes and can become resistant to treatment, leading to a continuing search for new drugs.
A new class of drug for people with HIV is being introduced in Britain today, which researchers describe as a huge step in treating the deadly infection.
The new drug is named Raltegravir and it is available in tablets form which is to be taken twice a day. It is approved for use with other antiretroviral drugs to treat HIV in about one in ten patients whose therapy has stopped working. Continue reading “Raltegravir, A New Drug For HIV Patients”